Clinical trial
The Impact of Optical Coherence Tomography on the Decision-making Process of Endovascular Treatment of Femoropopliteal Disease
NCT05057637 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Optical Coherence Tomography on the Decision-making Process of Endovascular Treatment of Femoropopliteal Disease
- Lead sponsor
- Rijnstate Hospital
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- March 9, 2022
- Completion date
- April 30, 2027
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
femoropopliteal stenosis